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Across all patients, children ages 0-4 years (P¼ .01) and 5-12
years (P¼ .001) predicted CRV infection. The allo group had
the greatest incidence of CRV infection (16%), and were most
sensitive to the presence of young children. Total number of
household members was not a predictor of CRV. The mean
number of days to CRV infection for all groups was 283 days
post-transplant.
Conclusions: Households with children in the age groups
of 0-4 and 5-12 more than doubled the risk of an HSCT
patient acquiring a CRV infection. Further studies are
needed to test interventions designed to interrupt house-
hold transmission of CRV from children to the vulnerable
HSCT patient. Household contacts, especially children,
should be included in transplant teaching. As indicated by
the potentially high number of days between transplant
and CRV infection, re-education and continuing focus on
CRV prevention should be reinforced throughout the post-
transplant period.
*0-4 year age group P¼ .01
**5-12 year age group P¼ .001539
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Serving as a caregiver for someone undergoing intense
cancer treatments, such as allogeneic transplantation, has
beneﬁts but also carries unavoidable psychological and
emotional effects, which may include loneliness. Loneliness
is deﬁned as feeling isolated or alone when one desires
connections with others. Cross-sectional data were drawn
from hematopoietic stem cell transplant (HSCT) caregivers
(CG) (n¼21) and matched (age, gender, race/ethnicity) non-
caregiver controls (MC) (n¼20) to examine their level of
loneliness and related factors.
Methods: Adult HSCT CGs literate in English/Spanish, pre-
HSCT, completed the Health Promoting Lifestyle Proﬁle-II,
General Self Efﬁcacy scale, PROMIS short forms and UCLA
Loneliness scale.Results: CGs were primarily female (66.7%), 50.8 years old
(+ 11.9) and spouse of the HSCT recipient (52.4%). Thirteen
(61.9%) were sole CGs while 38.1% were members of a CG
‘network’. Adult patients were preparing for a reduced
intensity (61.9%), peripheral blood (95.2%) related donor
(85.7%) HSCT for lymphoma (28.6%) or leukemia (33.3%).
CG loneliness scores were signiﬁcantly higher (p¼0.022)
than MCs (20.86 + 5.7 vs. 17.0 + 4.6), with male CGs
signiﬁcantly higher than male MCs. Sole male CGs who
were spouses reported highest loneliness scores. Loneli-
ness was signiﬁcantly related (P < .05) to interpersonal
relations, spiritual growth and self-efﬁcacy, suggesting CGs
with well-established relationships, spiritual connections
and conﬁdence in their caregiving abilities were less
lonely.
Conclusion: Conﬁdence as a CG is critical for HSCT patient
recovery but also CG well-being. Assessing loneliness in
HSCT CGs may be of value especially in groups at risk for
loneliness. Future research should explore interventions
that modify health behaviors such as developing relation-
ships and enhancing self-efﬁcacy in CGs and HSCT
recipients.
Acknowledgement: This research was supported by the
Intramural Research Program of the NIH, Clinical Center,
Nursing Research & Translational Science of the Nursing &
Patient Care Service.POSTER SESSION 2: TRANSPLANT PHARMACY
540
Intravenous Busulfan Pharmacokinetics in Conditioning
Regimens for Allogeneic Hematopoietic Stem Cell
Transplantation: Impact of Dosing Weight
Amber M. Bradley 1,2, Sarah Evans 2, David DeRemer 1,2,
Farrukh Tauseef Awan 3. 1 Georgia Health Sciences Medical
Center, Augusta, GA; 2 University of Georgia College of
Pharmacy, Augusta, GA; 3 Georgia Health Sciences University,
Augusta, GA
Introduction: The area-under-the curve (AUC) for busulfan
has been linked to clinical outcomes such as veno-occlusive
disease (VOD) and cancer relapse. The choice of body weight
(actual versus adjusted weight) to calculate the dose of
busulfan may be critical in attaining goal AUC based on
pharmacokinetic (PK) analysis, especially for overweight
patients.
Objective: Determine a correlation between weight chosen
for dosing of busulfan and outcomes.
Methods: An IRB-approved retrospective analysis was per-
formed on hematopoietic stem cell transplant (HSCT)
recipients who had received either Q6H IV busulfan with
cyclophosphamide (Bu/Cy) or once-daily IV busulfan with
ﬂudarabine (Flu/Bu) as conditioning regimens. All patients
underwent prospective monitoring of serum PKs at
a specialized therapeutic drug monitoring central laboratory.
Data was analyzed using Systat ver 13.
Results: Of the 31 patients with evaluable PK results, mean
age was 53 years; 48% were male; 77% were Caucasian and
58% had AML/MDS. GVHD prophylaxis consisted of tacroli-
mus/methotrexate in 58% and tacrolimus/mini-metho-
trexate in 42% of patients; 35% of the patients also received
anti-thymocyte globulin. With regards to conditioning
regimen, 58% received Flu/Bu (50% dosed on actual weight,
50% dosed on adjusted) and 42% received Bu/Cy (23% ¼
actual weight, 77% ¼ adjusted). Only two patients did not
require a dose adjustment based on AUC results. Overall,
